| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.092 | 0.03 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |